Home > Insider Trading > Filing (0001104659-25-012365)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773427	Springworks Therapeutics Inc.	SWTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1819465	Daniel Pichl	C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902	Chief People Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-02-10	13,750	$27.64	64,512	No	4	M	Direct
Common Stock	Acquisiton	2025-02-10	16,000	$27.64	80,512	No	4	M	Direct
Common Stock	Disposition	2025-02-10	13,750	$53.02	66,762	No	4	S	Direct
Common Stock	Disposition	2025-02-10	9,000	$54.25	57,762	No	4	S	Direct
Common Stock	Disposition	2025-02-10	7,000	$57.15	50,762	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-02-10	13,750	$0.00	13,750	$27.64
Common Stock	Stock Option (Right to Buy)	Disposition	2025-02-10	16,000	$0.00	16,000	$27.64

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,250		2033-01-05	No	4	M	Direct
32,750		2033-01-05	No	4	M	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on May 21, 2024.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.515. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option shall vest in 48 equal monthly installments subject to continued service to the Issuer by the Reporting Person.
Twenty-five percent (25%) of this option shall vest and become exercisable on January 5, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter subject to continued service to the Issuer by the Reporting Person.